Skip to content
Search:
Facebook
Twitter
Home
Cryptocurrency
Business
Economy
Personal finance
Markets
Health
medicine
Health care
Nutrition
Fitness
Health care
Entertainment
Movies
Tv
Music
Sports
Nba
Mlb
Nfl
Technology
Internet
Gadgets
Mobile
Make Money online
artificial intelligence
Search:
Facebook
Twitter
Home
Cryptocurrency
Business
Economy
Personal finance
Markets
Health
medicine
Health care
Nutrition
Fitness
Health care
Entertainment
Movies
Tv
Music
Sports
Nba
Mlb
Nfl
Technology
Internet
Gadgets
Mobile
Make Money online
artificial intelligence
Medical Conditions
Ozempic Settles the Obesity Debate: It's Biology Over Willpower – The Wall Street Journal
He Developed a Drug to Treat Psoriasis. He Also Had the Disease Himself. – The Wall Street Journal
Covid Vaccine Curse Claims BioNTech Stock
BioNTech Stock Falls After Earnings. The Vaccine Maker Missed Revenue Estimates.
AFib and Alcohol: What to Know About Causes, Prevention
U.K. Reviews Safety of Ozempic, Other Weight-Loss Drugs – The Wall Street Journal
Healthcare surges after strong earnings week – Healthcare Roundup
As the Ozympic/Wegovi debacle continues, Morgan Stanley raises forecasts for weight loss drugs to $77 billion.
The fight against Alzheimer’s goes beyond plaque. Tangles is also a target.
Biogen’s big Alzheimer’s drug win failed to boost its stock
Cancer-Drug Shortages Force Doctors to Offer Chemotherapy – WSJ – The Wall Street Journal
America’s pharmaceutical supply chain is a prescription for risk.
Posts navigation
1
2
3
…
7
Next Page